Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management

Journal of Infection

Volumn 60, Issue 1, 2010, Pages 1-20

  Checkley, Anna M ^a   Chiodini, Peter L ^a   Dockrell, David H ^b   Bates, Imelda ^c   Thwaites, Guy E ^a   Booth, Helen L ^d   Brown, Michael ^a   Wright, Stephen G ^a   Grant, Alison D ^a   Mabey, David C ^a   Whitty, Christopher J M ^a   Sanderson, Frances ^e  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Eosinophilia; Helminth; Investigation; Management; Migrant; Traveller

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; ANTIHISTAMINIC AGENT; ARTEMISININ DERIVATIVE; BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; DEXAMETHASONE; DIETHYLCARBAMAZINE; FLUCONAZOLE; ITRACONAZOLE; IVERMECTIN; MEBENDAZOLE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRAZIQUANTEL; PREDNISOLONE; STEROID; TRICLABENDAZOLE;

ABDOMINAL PAIN; AFRICA; ANCYLOSTOMA DUODENALE; ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS; ANGIOSTRONGYLUS CANTONENSIS; ANISAKIASIS; ANISAKIS; ASCARIASIS; ASCARIS LUMBRICOIDES; ASTHMA; ATOPY; BANCROFTIAN FILARIASIS; BRUGIA MALAYI; BRUGIAN FILARIASIS; CESTODIASIS; CLINICAL FEATURE; CLONORCHIASIS; CLONORCHIS SINENSIS; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; ECHINOCOCCUS MULTILOCULARIS; EDEMA; ENTEROBIASIS; ENTEROBIUS VERMICULARIS; EOSINOPHILIA; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; FEVER; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; GNATHOSTOMIASIS; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; HYMENOLEPIS NANA; HYPERSENSITIVITY REACTION; IMMIGRANT; INCUBATION TIME; JAUNDICE; LIVER HYDATID CYST; LOA LOA; LOEFFLER PNEUMONIA; LOIASIS; LUNG ALVEOLITIS; LUNG FIBROSIS; LUNG HYDATID CYST; LUNG INFILTRATE; LYMPHATIC FILARIASIS; MUSCULOSKELETAL DISEASE; NECATOR AMERICANUS; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPISTHORCHIASIS; OPISTHORCHIS; PARAGONIMIASIS; PARAGONIMUS; PARASITE TRANSMISSION; PRACTICE GUIDELINE; PRURITUS; REPEATED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SEROLOGY; SINGLE DRUG DOSE; SKIN MANIFESTATION; SOUTH AMERICAN BLASTOMYCOSIS; STRONGYLOIDES; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TAENIA SAGINATA; TAENIA SOLIUM; TAENIASIS; TOXOCARA CANIS; TOXOCARIASIS; TRAVEL; TRICHINELLA; TRICHINOSIS; TRICHURIASIS; TRICHURIS; TROPICS; UNITED KINGDOM; URINALYSIS; URINARY TRACT DISEASE; VISCERAL LARVA MIGRANS SYNDROME; WUCHERERIA BANCROFTI;

EOSINOPHILIA; FECES; GEOGRAPHY; GREAT BRITAIN; HELMINTHIASIS; HUMANS; SEROLOGIC TESTS; TRANSIENTS AND MIGRANTS; TRAVEL; TROPICAL CLIMATE;

EID: 73649101374     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.11.003     Document Type: Review

References (167)

1. Whitty C.J., Carroll B., Armstrong M., Dow C., Snashall D., Marshall T., et al. Utility of history, examination and laboratory tests in screening those returning to Europe from the tropics for parasitic infection. Trop Med Int Health 5 (2000) 818-823
2. Libman M.D., MacLean J.D., and Gyorkos T.W. Screening for schistosomiasis, filariasis, and strongyloidiasis among expatriates returning from the tropics. Clin Infect Dis 17 (1993) 353-359
3. Whetham J., Day J.N., Armstrong M., Chiodini P.L., and Whitty C.J. Investigation of tropical eosinophilia; assessing a strategy based on geographical area. J Infect 46 (2003) 180-185
4. Gill G.V., Beeching N.J., Khoo S., Bailey J.W., Partridge S., Blundell J.W., et al. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 98 (2004) 382-386
5. Gill G.V., Welch E., Bailey J.W., Bell D.R., and Beeching N.J. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Quart J Math 97 (2004) 789-795
6. Grove D.I. Strongyloidiasis in Allied ex-prisoners of war in south-east Asia. Br Med J 280 (1980) 598-601
7. Junker J., Eckardt L., and Husstedt I. Cervical intramedullar schistosomiasis as a rare cause of acute tetraparesis. Clin Neurol Neurosurg 103 (2001) 39-42
8. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
9. Heyns C.F., and van der Merwe A. Bladder cancer in Africa. Can J Urol 15 (2008) 3899-3908
10. Schulte C., Krebs B., Jelinek T., Nothdurft H.D., von Sonnenburg F., and Löscher T. Diagnostic significance of blood eosinophilia in returning travelers. Clin Infect Dis 34 (2002) 407-411
11. Sarner L., Fakoya A.O., Tawana C., Allen E., Copas A.J., Chiodini P.L., et al. The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London. Int J STD AIDS 18 (2007) 626-629
12. Tefferi A., Patnaik M.M., and Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 133 (2006) 468-492
13. Moore T.A., and Nutman T.B. Eosinophilia in the returning traveler. Infect Dis Clin North Am 12 (1998) 503-521
14. Gleich G.J., and Leiferman K.M. The hypereosinophilic syndromes: current concepts and treatments. Br J Haematol 145 (2009) 271-285
15. Afshar K., Vucinic V., and Sharma O.P. Eosinophil cell: pray tell us what you do!. Curr Opin Pulm Med 13 (2007) 414-421
16. López-Vélez R., Huerga H., and Turrientes M.C. Infectious diseases in immigrants from the perspective of a tropical medicine referral unit. Am J Trop Med Hyg 69 (2003) 115-121
17. Gyorkos T.W., Frappier-Davignon L., MacLean J.D., and Viens P. Effect of screening and treatment on imported intestinal parasite infections: results from a randomized, controlled trial. Am J Epidemiol 129 (1989) 753-761
18. Nutman T.B., Miller K.D., Mulligan M., and Ottesen E.A. Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis 154 (1986) 10-18
19. MacLean J.D., and Libman M. Screening returning travelers. Infect Dis Clin North Am 12 (1998) 431-443
20. Whitty C.J.M., Mabey D.C., Armstrong M., Wright S.G., and Chiodini P.L. Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country. Trans R Soc Trop Med Hyg 94 (2000) 531-534
21. Allen A.V., and Ridley D.S. Further observations on the formol-ether concentration technique for faecal parasites. J Clin Pathol 23 (1970) 545-546
22. Sudarshi S., Stümpfle R., Armstrong M., Ellman T., Parton S., Krishnan P., et al. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop Med Int Health 8 (2003) 728-732
23. Sinniah B. Daily egg production of Ascaris lumbricoides: the distribution of eggs in the faeces and the variability of egg counts. Parasitology 84 (1982) 167-175
24. Bierman W.F., Wetsteyn J.C., and van Gool T. Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med 12 (2005) 9-13
25. Harries A.D., Myers B., and Bhattacharrya D. Eosinophilia in Caucasians returning from the tropics. Trans R Soc Trop Med Hyg 80 (1986) 327-328
26. Bailey M.S., Thomas R., Green A.D., Bailey J.W., and Beeching N.J. Helminth infections in British troops following an operation in Sierra Leone. Trans R Soc Trop Med Hyg 100 (2006) 842-846
27. Visser L.G., Polderman A.M., and Stuiver P.C. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 20 (1995) 280-285
28. Bottieau E., Clerinx J., de Vega M.R., Van den Enden E., Colebunders R., Van Esbroeck M., et al. Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect 52 (2006) 339-345
29. Leshem E., Maor Y., Meltzer E., Assous M., and Schwartz E. Acute schistosomiasis outbreak: clinical features and economic impact. Clin Infect Dis 47 (2008) 1499-1506
30. WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 912 i-vi (2002) 1-57
31. Danso-Appiah A., Utzinger J., Liu J., and Olliaro P. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev 3 (2008) CD000053
32. Doenhoff M.J., and Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4 (2006) 199-210
33. Doherty J.F., Moody A.H., and Wright S.G. Katayama fever: an acute manifestation of schistosomiasis. Br Med J 313 (1996) 1071-1072
34. Hou X.Y., McManus D.P., Gray D.J., Balen J., Luo X.S., and He Y.K. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ 86 (2008) 788-795
35. Smith H., Holland C., Taylor M., Magnaval J.F., Schantz P., and Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol 25 (2009) 182-188
36. Teixeira C.R., Chieffi P.P., Lescano S.A., de Melo Silva E.O., Fux B., and Cury M.C. Frequency and risk factors for toxocariasis in children from a pediatric outpatient center in southeastern Brazil. Rev Inst Med Trop Sao Paulo 48 (2006) 251-255
37. Akao N., and Ohta N. Toxocariasis in Japan. Parasitol Int 56 (2007) 87-93
38. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 16 (2003) 265-272
39. Stürchler D., Schubarth P., Gualzata M., Gottstein B., and Oettli A. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol 83 (1989) 473-478
40. Vijayan V.K. Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management. Curr Opin Pulm Med 13 (2007) 428-433
41. Boggild A.K., Keystone J.S., and Kain K.C. Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity. Clin Infect Dis 39 (2004) 1123-1128
42. Ong R.K., and Doyle R.L. Tropical pulmonary eosinophilia. Chest 113 (1998) 1673-1679
43. Ottesen E.A., and Nutman T.B. Tropical pulmonary eosinophilia. Annu Rev Med 43 (1992) 417-424
44. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. WHO Tech Rep Ser 821 (1992) 1-53
45. Junghanss T., da Silva A.M., Horton J., Chiodini P.L., and Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 79 (2008) 301-311
46. Moro P., and Schantz P.M. Echinococcosis: a review. Int J Infect Dis 13 (2009) 125-133
47. Liu Q., Wei F., Liu W., Yang S., and Zhang X. Paragonimiasis: an important food-borne zoonosis in China. Trends Parasitol 24 (2008) 318-323
48. Nawa Y. Re-emergence of paragonimiasis. Intern Med 39 5 (2000 May) 353-354
49. Obara A., Nakamura-Uchiyama F., Hiromatsu K., and Nawa Y. Paragonimiasis cases recently found among immigrants in Japan. Intern Med 43 (2004) 388-392
50. Blair D., Xu Z.B., and Agatsuma T. Paragonimiasis and the genus Paragonimus. Adv Parasitol 42 (1999) 113-222
51. http://www.med.mcgill.ca/tropmed/txt/services.htm
52. Drugs for parasitic infections. Available at:. Med Lett Drugs Ther 5 Suppl. (2007). http://medlet-best.securesites.com/html/parasitic.htm
53. Parish J.M., and Blair J.E. Coccidioidomycosis. Mayo Clin Proc 83 (2008) 343-348
54. Desai S.A., Minai O.A., Gordon S.M., O'Neil B., Wiedemann H.P., and Arroliga A.C. Coccidioidomycosis in non-endemic areas: a case series. Respir Med 95 (2001) 305-309
55. Galgiani J.N., Ampel N.M., Blair J.E., Catanzaro A., Johnson R.H., Stevens D.A., et al. Infectious diseases society of America. Coccidioidomycosis. Clin Infect Dis 41 (2005) 1217-1223
56. Menezes V.M., Soares B.G., and Fontes C.J. Drugs for treating paracoccidioidomycosis. Cochrane Database Syst Rev 2 (2006) CD004967
57. http://www.pneumotox.com
58. Tillie-Leblond A.-B. Tonnel allergic bronchopulmonary aspergillosis. Allergy 60 (2005) 1004-1013
59. Cottin V., and Cordier J.-F. Eosinophilic pneumonias. Allergy 60 (2005) 841-857
60. Vijayan V.K., Reetha A.M., Jawahar M.S., Sankaran K., and Prabhakar R. Pulmonary eosinophilia in pulmonary tuberculosis. Chest 101 (1992) 1708-1709
61. Keiser P.B., and Nutman T.B. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17 (2004) 208-217
62. Scaglia M., Brustia R., Gatti S., Bernuzzi A.M., Strosselli M., Malfitano A., et al. Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases. Bull Soc Pathol Exot Filiales 77 (1984) 328-332
63. Sánchez P.R., Guzman A.P., Guillen S.M., Adell R.I., Estruch A.M., Gonzalo I.N., et al. Endemic strongyloidiasis on the Spanish Mediterranean coast. Quart J Math 94 (2001) 357-363
64. Siddiqui A.A., and Berk S.L. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33 (2001) 1040-1047
65. Sato Y., Kobayashi J., Toma H., and Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 53 (1995) 248-250
66. Hirata T., Nakamura H., Kinjo N., Hokama A., Kinjo F., Yamane N., et al. Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method. Am J Trop Med Hyg 77 (2007) 683-684
67. Toma H., Sato Y., Shiroma Y., Kobayashi J., Shimabukuro I., and Takara M. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 31 (2000) 147-151
68. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55 (1996) 477-481
69. Chiodini P.L., Reid A.J., Wiselka M.J., Firmin R., and Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 355 9197 (2000 Jan 1) 43-44
70. Turner S.A., Maclean J.D., Fleckenstein L., and Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 73 (2005) 911-914
71. Nicolls D.J., Weld L.H., Schwartz E., Reed C., von Sonnenburg F., Freedman D.O., et al., GeoSentinel Surveillance Network. Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008. Am J Trop Med Hyg 79 (2008) 729-734
72. Gryseels B., Polman K., Clerinx J., and Kestens L. Human schistosomiasis. Lancet 368 (2006) 1106-1118
73. Tosswill J.H., and Ridley D.S. An evaluation of the ELISA for schistosomiasis in a hospital population. Trans R Soc Trop Med Hyg 80 (1986) 435-438
74. Jones M.E., Mitchell R.G., and Leen C.L. Long seronegative window in schistosoma infection. Lancet 340 (1992) 1549-1550
75. Qiu D.C., Hubbard A.E., Zhong B., Zhang Y., and Spear R.C. A matched, case-control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China. Ann Trop Med Parasitol 99 (2005) 47-52
76. Blanchard T.J. Schistosomiasis. Travel Med Infect Dis 2 (2004) 5-11
77. Rabello A.L., Garcia M.M., Pinto da Silva R.A., Rocha R.S., and Katz N. Humoral immune responses in patients with acute Schistosoma mansoni infection who were followed up for two years after treatment. Clin Infect Dis 24 (1997) 304-308
78. Keiser J., and Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. J Am Med Assoc 299 (2008) 1937-1948
79. García H.H., González A.E., Del Brutto O.H., Tsang V.C., Llanos-Zavalaga F., Gonzalvez G., et al. Cysticercosis Working Group in Peru. Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci 262 (2007) 153-157
80. Mirdha B.R., and Samantray J.C. Hymenolepis nana: a common cause of paediatric diarrhoea in urban slum dwellers in India. J Trop Pediatr 48 (2002) 331-334
81. Schenone H. Praziquantel in the treatment of Hymenolepis nana infections in children. Am J Trop Med Hyg 29 (1980) 320-321
82. Farid Z., Ayad El-Masry N., and Wallace C.K. Treatment of Hymenolepis nana with a single oral dose of praziquantel. Trans R Soc Trop Med Hyg 78 (1984) 280-281
83. Tsibouris P., Galeas T., Moussia M., Sotiropoulou M., Michopoulos S., and Kralios N. Two cases of eosinophilic gastroenteritis and malabsorption due to Enterobious vermicularis. Dig Dis Sci 50 (2005) 2389-2392
84. Jardine M., Kokai G.K., and Dalzell A.M. Enterobius vermicularis and colitis in children. J Pediatr Gastroenterol Nutr 43 (2006) 610-612
85. Bruschi F., and Murrell K.D. New aspects of human trichinellosis: the impact of new Trichinella species. Postgrad Med J 78 (2002) 15-22
86. Capó V., and Despommier D.D. Clinical aspects of infection with Trichinella spp. Clin Microbiol Rev 9 (1996) 47-54
87. Murrell K.D., and Pozio E. Trichinellosis: the zoonosis that won't go quietly. Int J Parasitol 30 (2000) 1339-1349
88. Watt G., Saisorn S., Jongsakul K., Sakolvaree Y., and Chaicumpa W. Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis. J Infect Dis 182 (2000) 371-374
89. Pozio E., Sacchini D., Sacchi L., Tamburrini A., and Alberici F. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clin Infect Dis 15 32 (2001) 638-642
90. Shimoni Z., Klein Z., Weiner P., Assous M.V., and Froom P. The use of prednisone in the treatment of trichinellosis. Isr Med Assoc J 9 (2007) 537-539
91. Akbar A., and Ghosh S. Anisakiasis-a neglected diagnosis in the West. Dig Liver Dis 37 (2005) 7-9
92. Gómez B., Tabar A.I., Tuñón T., Larrínaga B., Alvarez M.J., García B.E., et al. Eosinophilic gastroenteritis and Anisakis. Allergy 53 (1998) 1148-1154
93. Moore D.A., Girdwood R.W., and Chiodini P.L. Treatment of anisakiasis with albendazole. Lancet 360 (2002) 54
94. Pacios E., Arias-Diaz J., Zuloaga J., Gonzalez-Armengol J., Villarroel P., and Balibrea J.L. Albendazole for the treatment of anisakiasis ileus. Clin Infect Dis 41 (2005) 1825-1826
95. Kramer M.H., Greer G.J., Quiñonez J.F., Padilla N.R., Hernández B., Arana B.A., et al. First reported outbreak of abdominal angiostrongyliasis. Clin Infect Dis 26 (1998) 365-372
96. Certad G., Arenas-Pinto A., Pocaterra L., Ferrara G., Castro J., Bello A., et al. Isosporiasis in Venezuelan adults infected with human immunodeficiency virus: clinical characterization. Am J Trop Med Hyg 69 (2003) 217-222
97. Apt W.B. Eosinophilia in Isospora infections. Parasitol Today 2 (1986) 22
98. Johnson E.H., Windsor J.J., and Clark C.G. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 17 (2004) 553-570
99. Eckert J., and Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 17 (2004) 107-135
100. Sadjjadi S.M. Present situation of echinococcosis in the Middle East and Arabic North Africa. Parasitol Int 55 Suppl. (2006) S197-S202
101. Romig T., Dinkel A., and Mackenstedt U. The present situation of echinococcosis in Europe. Parasitol Int 55 Suppl. (2006) S187-S191
102. Torgerson P.R., Oguljahan B., Muminov A.E., Karaeva R.R., Kuttubaev O.T., Aminjanov M., et al. Present situation of cystic echinococcosis in Central Asia. Parasitol Int 55 Suppl. (2006) S207-S212
103. Jenkins D.J., Romig T., and Thompson R.C. Emergence/re-emergence of Echinococcus spp. - a global update. Int J Parasitol 35 (2005) 1205-1219
104. Smego Jr. R.A., and Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 9 (2005) 69-76
105. Kern P., Wen H., Sato N., Vuitton D.A., Gruener B., Shao Y., et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 55 Suppl. (2006) S283-S287
106. Salimi-Bejestani M.R., Daniel R.G., Felstead S.M., Cripps P.J., Mahmoody H., and Williams D.J. Prevalence of Fasciola hepatica in dairy herds in England and Wales measured with an ELISA applied to bulk-tank milk. Vet Rec 156 (2005) 729-731
107. Marcos L.A., Terashima A., and Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 21 (2008) 523-530
108. Saba R., Korkmaz M., Inan D., Mamikoǧlu L., Turhan O., Günseren F., et al. Human fascioliasis. Clin Microbiol Infect 10 (2004) 385-387
109. Espinoza J.R., Timoteo O., and Herrera-Velit P. Fas2-ELISA in the detection of human infection by Fasciola hepatica. J Helminthol 79 (2005) 235-240
110. Hien T.T., Truong N.T., Minh N.H., Dat H.D., Dung N.T., Hue N.T., et al. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am J Trop Med Hyg 78 (2008) 388-392
111. Choi B.I., Han J.K., Hong S.T., and Lee K.H. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev 17 (2004) 540-552
112. Mairiang E., and Mairiang P. Clinical manifestation of opisthorchiasis and treatment. Acta Trop 88 (2003) 221-227
113. Lun Z.R., Gasser R.B., Lai D.H., Li A.X., Zhu X.Q., Yu X.B., et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 5 (2005) 31-41
114. Lo Re III V., and Gluckman S.J. Eosinophilic meningitis. Am J Med 114 (2003) 217-223
115. Chotmongkol V., Sawanyawisuth K., and Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 31 (2000) 660-662
116. Jitpimolmard S., Sawanyawisuth K., Morakote N., Vejjajiva A., Puntumetakul M., Sanchaisuriya K., et al. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. Parasitol Res 100 (2007) 1293-1296
117. Pien F.D., and Pien B.C. Angiostrongylus cantonensis eosinophilic meningitis. Int J Infect Dis 3 (1999) 161-163
118. Lv S., Zhang Y., Steinmann P., and Zhou X.N. Emerging angiostrongyliasis in Mainland China. Emerg Infect Dis 14 (2008) 161-164
119. Slom T.J., Cortese M.M., Gerber S.I., Jones R.C., Holtz T.H., Lopez A.S., et al. An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. N Engl J Med 28 346 (2002) 668-675
120. Hochberg N.S., Park S.Y., Blackburn B.G., Sejvar J.J., Gaynor K., Chung H., et al. Distribution of eosinophilic meningitis cases attributable to Angiostrongylus cantonensis, Hawaii. Emerg Infect Dis 13 (2007) 1675-1680
121. Punyagupta S., Juttijudata P., and Bunnag T. Eosinophilic meningitis in Thailand. Clinical studies of 484 typical cases probably caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 24 (1975) 921-931
122. Punyagupta S., Bunnag T., and Juttijudata P. Eosinophilic meningitis in Thailand. Clinical and epidemiological characteristics of 162 patients with myeloencephalitis probably caused by Gnathostoma spinigerum. J Neurol Sci 96 (1990) 241-256
123. Sithinamsuwan P., and Chairangsaris P. Images in clinical medicine. Gnathostomiasis - neuroimaging of larval migration. N Engl J Med 353 (2005) 188
124. Kraivichian P., Kulkumthorn M., Yingyourd P., Akarabovorn P., and Paireepai C.C. Albendazole for the treatment of human gnathostomiasis. Trans R Soc Trop Med Hyg 86 (1992) 418-421
125. Rangel-Castilla L., Serpa J.A., Gopinath S.P., Graviss E.A., Diaz-Marchan P., and White Jr. A.C. Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg 80 (2009) 373-378
126. Parija S.C., Sahu P.S., and Dhanya H. Detection of Cysticercus antigens and antibodies in cerebrospinal fluid of patients with chronic meningitis. Rev Inst Med Trop Sao Paulo 49 (2007) 331-334
127. Winkler A.S., Blocher J., Auer H., Gotwald T., Matuja W., and Schmutzhard E. Epilepsy and neurocysticercosis in rural Tanzania - an imaging study. Epilepsia 50 (2009) 987-993
128. Takayanagui O.M., and Odashima N.S. Clinical aspects of neurocysticercosis. Parasitol Int 55 Suppl. (2006) S111-S115
129. Garcia H.H., Del Brutto O.H., Nash T.E., White Jr. A.C., Tsang V.C., and Gilman R.H. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 72 (2005) 3-9
130. García H.H., Evans C.A., Nash T.E., Takayanagui O.M., White Jr. A.C., Botero D., et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15 (2002) 747-756
131. Carod-Artal F.J. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 102 (2008) 107-116
132. Jauréguiberry S., Ansart S., Perez L., Danis M., Bricaire F., and Caumes E. Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg 76 (2007) 964-966
133. Vidal J.E., Sztajnbok J., and Seguro A.C. Eosinophilic meningoencephalitis due to Toxocara canis: case report and review of the literature. Am J Trop Med Hyg 69 (2003) 341-343
134. Finsterer J., and Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 49 (2007) 279-287
135. Williams P.L. Coccidioidal meningitis. Ann N Y Acad Sci 1111 (2007) 377-384
136. Johnson R.H., and Einstein H.E. Coccidioidal meningitis. Clin Infect Dis 42 (2006) 103-107
137. Paniago A.M., de Oliveira P.A., Aguiar E.S., Aguiar J.I., da Cunha R.V., Leme L.M., et al. Neuroparacoccidioidomycosis: analysis of 13 cases observed in an endemic area in Brazil. Trans R Soc Trop Med Hyg 101 (2007) 414-420
138. Galgiani J.N., Cloud G.A., Catanzaro A., Johnson R.H., Mirels L.F., Stevens D.A., et al. Fluconazole (FLU) versus itroconazole (ITRA) for coccidioidomycosis: randomized, multicenter, double-blinded trial in nonmeningeal progressive infections. Clin Infect Dis 27 (1998) 939 [abstract 100]
139. Dewsnup D.H., Galgiani J.N., Graybill J.R., Diaz M., Rendon A., Cloud G.A., et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?. Ann Intern Med 124 (1996) 305-310
140. Walker M.D., and Zunt J.R. Neuroparasitic infections: cestodes, trematodes, and protozoans. Semin Neurol 25 (2005) 262-277
141. Kusner D.J., and King C.H. Cerebral paragonimiasis. Semin Neurol 13 (1993) 201-208
142. Heukelbach J., and Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis 8 (2008) 302-309
143. Hochedez P., and Caumes E. Hookworm-related cutaneous larva migrans. J Travel Med 14 (2007) 326-333
144. Starr J., Pruett J.H., Yunginger J.W., and Gleich G.J. Myiasis due to Hypoderma lineatum infection mimicking the hypereosinophilic syndrome. Mayo Clin Proc 75 (2000) 755-759
145. Navajas A., Cardenal I., Piñan M.A., Ortiz A., Astigarraga I., and Fdez-Teijeiro A. Hypereosinophilia due to myiasis. Acta Haematol 99 (1998) 27-30
146. Chakvetadze C., Bani-Sadr F., Develoux M., Le Breton C., and Pialoux G. Limb swelling with hypereosinophilia. Lancet 368 (2006) 1126
147. Ezzedine K., Malvy D., Dhaussy I., Steels E., Castelein C., De Dobbeler G., et al. Onchocerciasis-associated limb swelling in a traveler returning from Cameroon. J Travel Med 13 (2006) 50-53
148. McCarthy J.S., Ottesen E.A., and Nutman T.B. Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis 170 (1994) 736-741
149. Udall D.N. Recent updates on onchocerciasis: diagnosis and treatment. Clin Infect Dis 44 (2007) 53-60
150. Ottesen E.A. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 61 (2006) 395-441
151. Boussinesq M. Loiasis. Ann Trop Med Parasitol 100 (2006) 715-731
152. Rojas-Molina N., Pedraza-Sanchez S., Torres-Bibiano B., Meza-Martinez H., and Escobar-Gutierrez A. Gnathostomosis, an emerging foodborne zoonotic disease in Acapulco, Mexico. Emerg Infect Dis 5 2 (1999 Mar-Apr) 264-266
153. Chai J.Y., Han E.T., Shin E.H., Park J.H., Chu J.P., Hirota M., et al. An outbreak of gnathostomiasis among Korean emigrants in Myanmar. Am J Trop Med Hyg 69 1 (2003 Jul) 67-73
154. Díaz Camacho S.P., Willms K., de la Cruz Otero Mdel C., Zazueta Ramos M.L., Bayliss Gaxiola S., Castro Velázquez R., et al. Acute outbreak of gnathostomiasis in a fishing community in Sinaloa, Mexico. Parasitol Int 52 2 (2003 Jun) 133-140
155. Kraivichian K., Nuchprayoon S., Sitichalernchai P., Chaicumpa W., and Yentakam S. Treatment of cutaneous gnathostomiasis with ivermectin. Am J Trop Med Hyg 71 5 (2004 Nov) 623-628
156. Nontasut P., Bussaratid V., Chullawichit S., Charoensook N., and Visetsuk K. Comparison of ivermectin and albendazole treatment for gnathostomiasis. Southeast Asian J Trop Med Public Health 31 2 (2000 Jun) 374-377
157. Nontasut P., Claesson B.A., Dekumyoy P., Pakdee W., and Chullawichit S. Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis. Southeast Asian J Trop Med Public Health 36 3 (2005 May) 650-652
158. Verbrugge L.M., Rainey J.J., Reimink R.L., and Blankespoor H.D. Prospective study of swimmer's itch incidence and severity. J Parasitol 90 4 (2004 Aug) 697-704
159. Lévesque B., Giovenazzo P., Guerrier P., Laverdière D., and Prud'Homme H. Investigation of an outbreak of cercarial dermatitis. Epidemiol Infect 129 2 (2002 Oct) 379-386
160. Day J.H., Grant A.D., Doherty J.F., Chiodini P.L., and Wright S.G. Schistosomiasis in travellers returning from sub-Saharan Africa. Br Med J 313 (1996) 268-269
161. Brouwer M.L., Tolboom J.J., and Hardeman J.H. Routine screening of children returning home from the tropics: retrospective study. Br Med J 318 (1999) 568-569
162. Ross A.G., Bartley P.B., Sleigh A.C., Olds G.R., Li Y., Williams G.M., et al. Schistosomiasis. N Engl J Med 346 (2002) 1212-1220
163. Mott K.E., Dixon H., Osei-Tutu E., and England E.C. Relation between intensity of Schistosoma haematobium infection and clinical haematuria and proteinuria. Lancet 1 (1983) 1005-1008
164. Wilson M., Bryan R.T., Fried J.A., Ware D.A., Schantz P.M., Pilcher J.B., et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164 (1991) 1007-1009
165. Furrows S.J., McCroddan J., Bligh W.J., and Chiodini P. Lack of specificity of a single positive 50-kDa band in the electroimmunotransfer blot (EITB) assay for cysticercosis. Clin Microbiol Infect 12 (2006) 459-462
166. Andrews J.A., Bligh W.J., Chiodini P.L., Bradley J.E., Nde P.N., and Lucius R. The role of a recombinant hybrid protein based ELISA for the serodiagnosis of Onchocerca volvulus. J Clin Pathol 61 (2008) 347-351
167. Dunyo S.K., Nkrumah F.K., and Simonsen P.E. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg 94 (2000) 205-211